Hodgkin lymphoma is a rare B-cell malignant neoplasm affecting approximately 9000 new
patients annually. This disease represents approximately 11% of all lymphomas seen in the …

Abstract Disease Overview Hodgkin lymphoma (HL) is an uncommon B‐cell lymphoid
malignancy affecting 8500 new patients annually and representing approximately 10.2% of …

Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …

Purpose Standardized response criteria are needed to interpret and compare clinical trials
and for approval of new therapeutic agents by regulatory agencies. Methods The …

Purpose To investigate whether bone marrow biopsy (BMB) adds useful information to [18F]
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) …

18-F-fluorodeoxyglucose (FDG)–positron emission tomography (PET), and more recently
PET/computed tomography (CT), is the most sensitive and specific imaging technique …

Functional imaging with positron emission tomography (PET) is playing an increasingly
important role in the diagnosis and staging of malignant disease, image-guided therapy …

International guidelines recommend that positron emission tomography-computed
tomography (PET-CT) should replace CT in Hodgkin lymphoma (HL). The aims of this study …

Fluoro-deoxyglucose positron emission tomography (FDG-PET) is a noninvasive, 3-
dimensional imaging modality that has become widely used in the management of patients …

PURPOSE: To retrospectively compare diagnostic value of coregistered fluorine 18
fluorodeoxyglucose positron emission tomographic (PET) and computed tomographic (CT) …